NTRA as of Oct 31 · 00:46 ET
NTRANasdaqServices-Medical Laboratories

Natera, Inc. · Brief

Next report

5 days

Nov 5 · after closeest.Q3 FY26

Expected move

Inputs

Implied vs realized

8 reportsHistory
—≥ implied
Feb 27 '25—▼−0.65%—
May 8 '25—▼−6.53%—
Aug 7 '25—▲+7.70%—
Q3 FY25—▲+0.55%—
Jan 12 '26—▲+1.04%—
Q1 FY26—▼−3.73%—
May 7 '26—▼−11.64%—
Q2 FY26±9.7%▲+21.37%×2.20
quarterimplied−25%0+25%realized×
Q2 FY26±9.7%▲+21.37%×2.20
May '26—▼−11.64%—
Q1 FY26—▼−3.73%—
Jan '26—▲+1.04%—
Q3 FY25—▲+0.55%—
Aug '25—▲+7.70%—
2 older reports
May '25—▼−6.53%—
Feb '25—▼−0.65%—
Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Bull & bear

Nov 5 report · est.

Bull2 of 4

2customers disclosing NTRA as a supplierSEC filings
14disclosed supplier and customer ties in SEC filingsSEC filings

Bear2 of 3

5 of 22of the largest reporting managers cut their stake in the latest quarter13F · Jun 30 '26
1.24%of ARK Innovation ETF's assets, the largest tracked-fund weightN-PORT · Jul 31 '26
AI captions · Sep 28 '26once per report · top 2 per case

Linked exposure

NTRA report session
× = co-movement · max 500dSource: SEC filings · market data

Latest changes

30 daysAll changes
Oct 22impliedImplied move: ±12.2% into Nov 5 earnings (Oct 22 close).Source

Your note

privateThesis 0 · Decisions 0 · Observations 0

No thesis.